Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Teva
Moodys
Boehringer Ingelheim
Deloitte
Cantor Fitzgerald
Covington
Cipla
AstraZeneca

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205650

« Back to Dashboard
NDA 205650 describes PYRIDOSTIGMINE BROMIDE, which is a drug marketed by Impax Labs, Ani Pharms Inc, Us Army, Alvogen Malta, Zydus Pharms Usa Inc, Impax Labs Inc, Kinedexe Uk, and Solvay, and is included in nine NDAs. It is available from eight suppliers. Additional details are available on the PYRIDOSTIGMINE BROMIDE profile page.

The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.

Summary for NDA: 205650

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 205650

Mechanism of ActionCholinesterase Inhibitors

Suppliers and Packaging for NDA: 205650

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET;ORAL 205650 ANDA Major Pharmaceuticals 0904-6622 0904-6622-61 100 BLISTER PACK in 1 CARTON (0904-6622-61) > 1 TABLET in 1 BLISTER PACK
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET;ORAL 205650 ANDA Bryant Ranch Prepack 63629-5699 63629-5699-1 60 TABLET in 1 BOTTLE (63629-5699-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Jun 22, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Cantor Fitzgerald
UBS
Healthtrust
Argus Health
McKinsey
AstraZeneca
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot